Cargando…

International physician survey on management of FOP: a modified Delphi study

Fibrodysplasia ossificans progressiva (FOP), a disabling disorder of progressive heterotopic ossification (HEO), is caused by heterozygous gain-of- function mutations in Activin receptor A, type I (ACVR1, also known as ALK2), a bone morphogenetic protein (BMP) type I receptor. Presently, symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Rocco, Maja, Baujat, Genevieve, Bertamino, Marta, Brown, Matthew, De Cunto, Carmen L., Delai, Patricia L. R., Eekhoff, Elisabeth M. W., Haga, Nobuhiko, Hsiao, Edward, Keen, Richard, Morhart, Rolf, Pignolo, Robert J., Kaplan, Frederick S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Position Statement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468985/ https://www.ncbi.nlm.nih.gov/pubmed/28606101 http://dx.doi.org/10.1186/s13023-017-0659-4

Ejemplares similares

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization
por: Pignolo, Robert J., et al.
Publicado: (2021)

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
por: Ingen-Housz-Oro, S., et al.
Publicado: (2023)

European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis
por: Irving, Melita, et al.
Publicado: (2023)

Real-world evidence in achondroplasia: considerations for a standardized data set
por: Alanay, Yasemin, et al.
Publicado: (2023)

Parkinson’s disease in Gaucher disease patients: what’s changing in the counseling and management of patients and their relatives?
por: Di Rocco, Maja, et al.
Publicado: (2020)

Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?
por: Berg, D., et al.
Publicado: (2020)

International Association for Hospice and Palliative Care Position Statement: Euthanasia and Physician-Assisted Suicide
por: De Lima, Liliana, et al.
Publicado: (2017)

AOASM Position Statement on Esports, Active Video Gaming, and the Role of the Sports Medicine Physician
por: Franks, R. Robert, et al.
Publicado: (2022)

ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable
por: Brannagan, Thomas H., et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
por: Pignolo, Robert J., et al.
Publicado: (2020)

CSANZ Position Statement on COVID-19 From the Paediatric and Congenital Council(✰)
por: Ayer, Julian, et al.
Publicado: (2020)

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
por: Chiang, Jane L., et al.
Publicado: (2014)

Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic
por: Brizola, E., et al.
Publicado: (2020)

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus
por: Grandis, M., et al.
Publicado: (2020)

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
por: Perros, P., et al.
Publicado: (2017)

Nutrition Therapy Recommendations for the Management of Adults With Diabetes
por: Evert, Alison B., et al.
Publicado: (2013)

World netball cardiac screening guidelines
por: Bogwasi, L, et al.
Publicado: (2022)

Implications of COVID-19 for resumption of sport in South Africa: A South African Sports Medicine Association (SASMA) position statement – Part 2
por: Ramagole, DA, et al.
Publicado: (2020)

Implications of COVID-19 for resumption of sport in South Africa: A South African Sports Medicine Association (SASMA) position statement – Part 1
por: Ramagole, DA, et al.
Publicado: (2020)

BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening
por: Hsu, William C., et al.
Publicado: (2015)

Canadian Academy of Sport and Exercise Medicine Position Paper: The Clinician’s Role in Addressing and Preventing Maltreatment in Sport—10-year Anniversary
por: Stirling, Ashley E., et al.
Publicado: (2023)

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
por: Giustina, A., et al.
Publicado: (2014)

European principles of inhibitor management in patients with haemophilia
por: Giangrande, P. L. F., et al.
Publicado: (2018)

Methodological Issues in Soccer Talent Identification Research
por: Bergkamp, Tom L. G., et al.
Publicado: (2019)

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Diabetic Neuropathy: A Position Statement by the American Diabetes Association
por: Pop-Busui, Rodica, et al.
Publicado: (2017)

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
por: Chiang, Jane L., et al.
Publicado: (2018)

Diabetic Retinopathy: A Position Statement by the American Diabetes Association
por: Solomon, Sharon D., et al.
Publicado: (2017)

Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia
por: Hoy, Ryan, et al.
Publicado: (2020)

Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement
por: Colberg, Sheri R., et al.
Publicado: (2010)

Digitalisation and COVID-19: The Perfect Storm
por: Horgan, Denis, et al.
Publicado: (2020)

Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association
por: Chawla, Jasneek, et al.
Publicado: (2021)

Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus
por: Arima, Hiroshi, et al.
Publicado: (2022)

Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus
por: Arima, Hiroshi, et al.
Publicado: (2023)

Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*
por: Jee, Adelle S., et al.
Publicado: (2020)

Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ)
por: Nicholls, Stephen J., et al.
Publicado: (2020)

Cross-cutting view of current challenges in paediatric solid organ and haematopoietic stem cell transplantation in Europe: the European Reference Network TransplantChild
por: Jara, P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_afjn7ducfeotgavpb9pl73n6uh